Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells

Leukemia (2015) - Comments
pubmed: 25482131 doi: 10.1038/leu.2014.340 issn: 1476-5551 issn: 0887-6924

W Fiskus, S Sharma, S Saha, B Shah, S G T Devaraj, B Sun, S Horrigan, C Leveque, Y Zu, S Iyer, K N Bhalla